AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BERLYNE, G. M.
Right arrow Articles by GINKS, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BERLYNE, G. M.
Right arrow Articles by GINKS, W. R.
Agricola
Right arrow Articles by BERLYNE, G. M.
Right arrow Articles by GINKS, W. R.

American Journal of Clinical Nutrition, Vol 21, 547-552, Copyright © 1968 by The American Society for Clinical Nutrition, Inc.

Dietary Treatment of Chronic Renal Failure

G. M. BERLYNE M.D., M.R.C.P.1, D. GAAN M.B., M.R.C.P.1, and W. R. GINKS M.B.1

1 From the University Department of Medicine, Manchester Royal Infirmary, Manchester, England

The diet prolongs a comfortable existence. The clinical effects are rewarding, but management of salt, water, phosphate, and potassium abnormalities requires care and the use of drugs such as aluminum hydroxide and calcium Zeocarb 225. Bleeding and agitation may appear and are harbingers of death, usually within 5 days. Severe acidosis and hyperkalemia suggest death in a few weeks unless vigorously treated. The prognosis is particularly poor in malignant hypertensive patients and fairly good in nonhypertensive polycystic disease of the kidneys and chronic glomerulonephritis.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1968 by The American Society for Nutrition